Evidence & regulatory context
- Mechanism
- ChEMBL name search returned ZERO records for 'rotenone' on two attempts (lower and title case), so no ChEMBL identity is asserted. ClinicalTrials.gov searched: 0 hits. Rotenone is a mitochondrial complex I inhibitor used as a research/toxicological tool, not a human therapeutic.
- Target
- Not recorded
- Injury models
- Ischaemia-reperfusion
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatIschaemia-reperfusionCerebral (MCAO/stroke)WistarMaleIntravenous, tail vein0.01 mg/kg20 minutes before ischaemia
Model: Total brain ischaemia, with brains removed from anaesthetised rats and subjected to 120 minutes of ischaemia
Intravenous rotenone given 20 minutes before ischaemia increased resistance to calcium-induced pore opening and decreased reactive oxygen species production in mitochondria isolated from ischaemia-damaged cortex and cerebellum, and reduced infarct size in both regions. Added directly to normal cort…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.